RIKEN Center for Integrative Medical Sciences (IMS)

The RIKEN Center for Integrative Medical Sciences (IMS) is a leading biomedical research institute in Japan focused on understanding human health and disease through interdisciplinary research combining biology, medicine, genomics, and computational science. Established in 2013 as part of RIKEN, Japan’s largest comprehensive research institution, IMS is headquartered in Yokohama, Japan.

RIKEN IMS conducts advanced research in areas including genomics, immunology, cancer biology, human genetics, microbiome science, aging research, and precision medicine. The institute aims to understand the complex interactions between genes, cells, biological systems, and environmental factors that influence human health.

The center operates advanced research platforms involving next-generation sequencing, single-cell analysis, bioinformatics, artificial intelligence, and systems biology. These technologies allow scientists to study diseases at molecular and cellular levels and develop new approaches for diagnosis, prevention, and treatment.

RIKEN IMS collaborates with universities, hospitals, pharmaceutical companies, biotechnology organizations, and international research institutions. Its research contributes to discoveries in areas such as immune system regulation, cancer mechanisms, rare diseases, and personalized healthcare.

The institute promotes interdisciplinary collaboration by bringing together researchers from different scientific backgrounds, including genetics, computational biology, molecular biology, and medical science. It also supports young researchers through training programs and international scientific partnerships.

RIKEN IMS follows strict research ethics, laboratory safety, and scientific quality standards. Through innovative biomedical research and global collaboration, the institute continues to contribute significantly to advances in life sciences and the future development of precision medicine.